Targeting RET-rearranged non-small-cell lung cancer: future prospects

por Bronte G, Ulivi P, Verlicchi A, Cravero P, Delmonte A, Crinò L
Publicado 2019

Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Stud...

por Gadgeel S, Shaw AT, Barlesi F, Crino L, Yang JCH, Dingemans AM, Kim DW, de Marinis F, Schulz M, Liu S, Gupta R, Smoljanovic V, Ou SHI
Publicado 2019